Association Between HbA1c Levels and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Cardiovascular Disease: A Secondary Analysis of the TECOS Randomized Clinical Trial
ConclusionHbA1c exhibits a U ‐shaped association with cardiovascular outcomes in patients with T2D and atherosclerotic vascular disease, with nadir around 7%.This article is protected by copyright. All rights reserved.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Finlay A. McAlister,
Yinggan Zheng,
Cynthia M. Westerhout,
John B. Buse,
Eberhard Standl,
Darren K. McGuire,
Frans Van de Werf,
Jennifer B. Green,
Paul W. Armstrong,
Rury R. Holman,
on behalf of
the TECOS Study Group Tags: Research Article Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Attack | Heart Failure | Januvia | Stroke | Study